These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21398645)

  • 1. Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.
    Schwitter J; Arai AE
    Eur Heart J; 2011 Apr; 32(7):799-809. PubMed ID: 21398645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cardiovascular magnetic resonance in the management of patients with stable coronary artery disease.
    Motwani M; Swoboda PP; Plein S; Greenwood JP
    Heart; 2018 Jun; 104(11):888-894. PubMed ID: 29170357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance for the assessment of coronary artery disease.
    Gotschy A; Niemann M; Kozerke S; Lüscher TF; Manka R
    Int J Cardiol; 2015 Aug; 193():84-92. PubMed ID: 25661667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of cardiac magnetic resonance imaging.
    Pilz G; Heer T; Harrer E; Ali E; Hoefling B
    Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.
    Antiochos P; Ge Y; Steel K; Bingham S; Abdullah S; Mikolich JR; Arai AE; Bandettini WP; Patel AR; Farzaneh-Far A; Heitner JF; Shenoy C; Leung SW; Gonzalez JA; Shah DJ; Raman SV; Ferrari VA; Schulz-Menger J; Stuber M; Simonetti OP; Kwong RY;
    J Am Coll Cardiol; 2020 Aug; 76(8):945-957. PubMed ID: 32819469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of perfusion over wall-motion abnormalities with the use of dobutamine-atropine stress myocardial contrast echocardiography and magnetic resonance imaging for detecting coronary artery disease.
    Falcão SN; Rochitte CE; Junior WM; Quaglia L; Lemos PA; Sbano JC; Ramires JA; Kalil Filho R; Tsutsui JM
    Echocardiography; 2013 Jan; 30(1):45-54. PubMed ID: 23006451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease.
    Berman DS; Hachamovitch R; Shaw LJ; Friedman JD; Hayes SW; Thomson LE; Fieno DS; Germano G; Slomka P; Wong ND; Kang X; Rozanski A
    J Nucl Med; 2006 Jan; 47(1):74-82. PubMed ID: 16391190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of chronic myocardial ischemia. Role of cardiac magnetic resonance imaging].
    de Waha S; Eitel I; Desch S; Fuernau G; Lurz P; Schuler G; Thiele H
    Herz; 2013 Jun; 38(4):350-8. PubMed ID: 23604110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular magnetic resonance imaging in ischemic heart disease.
    von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Magn Reson Imaging; 2012 Jul; 36(1):20-38. PubMed ID: 22696124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined non-invasive functional and anatomical diagnostic work-up in clinical practice: the magnetic resonance and computed tomography in suspected coronary artery disease (MARCC) study.
    Groothuis JG; Beek AM; Brinckman SL; Meijerink MR; van den Oever ML; Hofman MB; van Kuijk C; van Rossum AC
    Eur Heart J; 2013 Jul; 34(26):1990-8. PubMed ID: 23475530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease.
    Jerosch-Herold M; Kwong RY
    Curr Opin Cardiol; 2008 Nov; 23(6):599-606. PubMed ID: 18830076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial).
    Schwitter J; Wacker CM; Wilke N; Al-Saadi N; Sauer E; Huettle K; Schönberg SO; Debl K; Strohm O; Ahlstrom H; Dill T; Hoebel N; Simor T;
    J Cardiovasc Magn Reson; 2012 Sep; 14(1):61. PubMed ID: 22938651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial perfusion imaging by cardiac magnetic resonance.
    Schwitter J
    J Nucl Cardiol; 2006 Nov; 13(6):841-54. PubMed ID: 17174815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of ischaemic burden in angiographic three-vessel coronary artery disease with high-resolution myocardial perfusion cardiovascular magnetic resonance imaging.
    Motwani M; Maredia N; Fairbairn TA; Kozerke S; Greenwood JP; Plein S
    Eur Heart J Cardiovasc Imaging; 2014 Jun; 15(6):701-8. PubMed ID: 24493156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia.
    Kuijpers D; Janssen CH; van Dijkman PR; Oudkerk M
    Eur Radiol; 2004 Oct; 14(10):1823-8. PubMed ID: 15278415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease.
    Jogiya R; Kozerke S; Morton G; De Silva K; Redwood S; Perera D; Nagel E; Plein S
    J Am Coll Cardiol; 2012 Aug; 60(8):756-65. PubMed ID: 22818072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-heart dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: determination of volumetric myocardial ischaemic burden and coronary lesion location.
    Manka R; Paetsch I; Kozerke S; Moccetti M; Hoffmann R; Schroeder J; Reith S; Schnackenburg B; Gaemperli O; Wissmann L; Wyss CA; Kaufmann PA; Corti R; Boesiger P; Marx N; Lüscher TF; Jahnke C
    Eur Heart J; 2012 Aug; 33(16):2016-24. PubMed ID: 22677136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol.
    Bernhardt P; Spiess J; Levenson B; Pilz G; Höfling B; Hombach V; Strohm O
    JACC Cardiovasc Imaging; 2009 Nov; 2(11):1292-300. PubMed ID: 19909933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases.
    Wahl A; Paetsch I; Gollesch A; Roethemeyer S; Foell D; Gebker R; Langreck H; Klein C; Fleck E; Nagel E
    Eur Heart J; 2004 Jul; 25(14):1230-6. PubMed ID: 15246641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.